CD4 and neoplasm: In addition, we have clearly shown that tumor regression is driven by CD4+ T cells, since the peripheral depletion of this compartment completely abolishes the anti-tumoral effects of CPIs, while the efficacy was maintained despite CD8+ T cell depletion.